View this email online

Stay up-to-date with the latest O&T News in Europe

Read EFORT's official Newsletter with a round up of all EFORT activities

Issue I - July 2022

New EFORT Board

Strong and diverse representation of European O&T

In Lisbon, after two years of virtual congresses, the General Assembly of EFORT finally took place on 21 June 2022 face-to-face.

During this meeting, the National Delegates voted in the new Board of EFORT.

Following the elections and the succession of previous members, the new EFORT Board for the period 2022/2023 is as follows: 

  • EFORT President: Prof. Dr. Enrique Gómez Barrena, Spain
  • First Vice President: Mr. David Limb, United Kingdom
  • Second Vice President: Prof. Dr. Theofilos Karachalios, Greece
  • Immediate Past President: Prof. Dr. Li Felländer-Tsai, Sweden
  • Secretary General: Prof. Dr. Rob Nelissen, the Netherlands
  • Treasurer: Prof. Dr. Gilles Pasquier, France
  • Member at Large: Prof. Dr. Katre Maasalu, Estonia
  • Member at Large: Prof. Dr. Stefan Nehrer, Austria
  • Member at Large: Dr. René Mihalič, Slovenia
  • Young Member at Large: Dr. Filipe Lima Santos, Portugal

We welcome all new Board members, who took their positions immediately after the 23rd EFORT Annual Congress in Lisbon, and the new Finance Committee members and thank all Board members who have left the Board for their hard work and dedication over the past years.

23rd EFORT annual Congress

Best National Paper Awards

As an overarching goal in launching this award, stood the ambition to create a Research Culture within the EFORT community. It was first introduced for the Virtual EFORT Congress in 2020.

As the final scientific highlight of the 23rd EFORT Annual Congress in Lisbon, EFORT organised the Best National Free Paper session focusing on the presentation of the best research projects among all competing posters (19 applications) submitted by our National Member Societies.

As a brief reminder, out of the 19 submissions, Best National Papers are then selected during poster walks onsite. Each of these will then feed a free paper session during which the respective presenting authors have the opportunity to explain their work and results to an expert panel.

The Q&A session concluding the presentation part drives a truly interactive exchange. At the very end, attendees from the audience are asked to vote and to choose the best oral presentation. This year’s winners are:

Denmark • Dr. Anders El-Galaly ››› The Risk Of Symptomatic Venous Thromboembolism Following Primary Total Knee Arthroplasty Performed With And Without Tourniquet - A Danish Nationwide Cohort Study Of 19,804 Patients

Poland • Mr. Bartosz Maciag ››› Establishing Femoral Component Rotation Using Dynamic Tensioner Improves Patellar Position After Total Knee Replacement With Use Of Anatomic Implants - Randomized-Controlled Trial

Turkey • Dr. Riza Mert Cetik ››› The Effects Of Transforming Growth Factor-Beta 3 (TGF-ß3) Loaded Nanoparticles On Rat Achilles Tendon Healing

Congratulations to all the winners and thank you to all the candidates who have submitted their work to make this award a stimulating experience between the National Societies, EFORT and the O&T community.


EFORT Open Reviews

High-quality instructional peer-reviewed articles

across the whole field of Orthopaedics and Traumatology


from EFORT Instructional Lectures

VOL.7, N° 6, JUNE 2022

EFORT Congress Special Issue

📄 Explant analysis and implant registries are both needed to further improve patient safety

M M Morlock, E Gomez-Barrena, D C Wirtz, A Hart, and J P Kretzer


📄 Optimizing indications

and technique in osteotomies

around the knee

Andrea Ferrera 

and Jacques Menetrey


📄 Acetabular fractures treatment needs in the elderly and nonagenarians

Julia Riemenschneider, Jan Tilmann Vollrath, Nils Mühlenfeld, Johannes Frank, Ingo Marzi, and Maren Janko

News following the release of the latest Journal Citation ReportsTM

The EFORT Open Reviews Editorial Board is delighted to announce that the journal has achieved an increased 2021 Journal Impact Factor of 4.775, with the Five-Year Impact Factor measure also increasing to 5.471.

What a great achievement!

EFORT Open Reviews now ranks in the Top Ten journals in the field of Orthopedics, Journal Citation Reports (Web of Science Group, 2022).

We would like to extend our deepest thanks to the authors, reviewers, readers and our world-class Editors, who continue to support the journal.

EFORT e-learning

Save the date for these upcoming

EFORT Webinars & EFORT Industry Collaborative Webinars (ICW)

13 September 2022 | EFORT ICW with Lima Corporate

New Technologies in Cementless Total Knee Replacement

20 September 2022 | EFORT ICW with LG Chem

Therapeutic Benefits of Crosslinked HA

26 September 2022 | EFORT Webinar

Cartilage Repair: Where we are

18 October 2022 | EFORT ICW with Tecres

Periprosthetic Joint Infection 

31 October 2022 | EFORT Webinar

Orthopaedic Paediatric Clinical Evaluation 

08 November 2022 | EFORT ICW with Nanjing Fito Medical

Short stems or the knee surgical technique 

28 November 2022 | EFORT Webinar

Hip Fractures in Young Adults

13 December 2022 | EFORT ICW with Amplitude

I use the Australian registry in my daily practice 

EFORT Webinars are organised by EFORT independently of any commercial educational support. EFORT Industry Collaborative Webinars are organised with the support of our corporate partners.


Industry O&T Product News

If it's not broken don't fix it*

Top bone substitute material for effective antibiotic

and bone defect treatment outcomes

A Q&A with Professor Dr. Christian Heiss

Proper antibiotic drug delivery system is imperative when managing either acute or chronic infections following bone trauma or defects.

Professor Dr. h.c. Christian Heiss, head of the Department of Trauma, Hand and Reconstructive Surgery at the University Hospital of Giessen gave information to EFORT about synthetic, biodegradable and osteoconductive bone substitute material for restoration and filling of bone defects.

We asked Prof. Dr. Heiss to tell us more about his experience with synthetic bone substitutes, beyond the vast amount of supporting clinical data. He summed up his reasoning for including them as a mainstay in his practice with a pun only a truly experienced orthopaedic surgeon could make, “If it isn’t broken, why fix it?” 


Sponsored ads*


*This section provides news, offers and an overview of orthopaedic & traumatology-related products in form of paid advertisement plans. We believe the information to be accurate, timely and qualitatively high enough to interest the orthopaedic and traumatology community, however due to the fact that we rely on information provided by external sources we are not in a position to make any warranty or guarantee concerning the accuracy or reliability of the content at this site or other sites to which we link. Hence their scientific content is not necessarily endorsed by EFORT, unless stated otherwise.


EFORT Resources

A quick access to prime educational material



LinkedInFacebookInstagramTwitterYouTubeEmail Address